当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析 - 资产负债表

康泰生物

(300601)

  

流通市值:191.05亿  总市值:243.82亿
流通股本:8.75亿   总股本:11.17亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,032,022,400.09775,519,766.67953,006,393.211,017,621,857.91
应收票据及应收账款2,652,769,031.392,753,973,604.192,480,290,407.212,293,300,975.88
应收账款2,652,769,031.392,753,973,604.192,480,290,407.212,293,300,975.88
应收款项融资245,070---
预付款项59,788,618.0255,574,550.9473,991,164.85110,038,728.66
其他应收款合计11,038,255.3310,458,831.5811,745,847.7811,381,730.02
存货852,438,881.27810,037,183.42797,143,098.54727,799,494.89
其他流动资产802,581,902.071,007,505,116.57784,482,671.6573,879,538.94
流动资产平衡项目0000
流动资产合计5,429,005,148.745,431,093,463.755,118,815,788.675,174,850,130.69
非流动资产:
投资性房地产49,206.7849,206.7849,206.7849,206.78
固定资产3,082,596,043.662,072,857,698.461,691,056,307.551,712,969,610.71
在建工程2,732,862,053.213,451,794,863.693,602,178,122.093,463,155,578.17
无形资产434,917,363.19348,813,080.27353,126,067.44357,978,813.58
开发支出66,037,196.16152,683,369.78132,580,598.04117,184,069.3
长期待摊费用117,979,922.7874,874,203.6472,181,967.778,761,560.59
递延所得税资产630,324,963.41653,445,529.17672,220,268.11708,319,053.95
其他非流动资产2,229,562,261.182,099,531,640.942,162,433,327.892,173,083,647.38
非流动资产平衡项目0000
非流动资产合计9,294,329,010.378,854,049,592.738,685,825,865.68,611,501,540.46
资产平衡项目0000
资产总计14,723,334,159.1114,285,143,056.4813,804,641,654.2713,786,351,671.15
流动负债:
短期借款166,447,687.5166,385,187.5167,308,333.33170,070,833.33
应付票据及应付账款752,593,414.7478,313,042.98445,693,846.38434,132,425.24
其中:应付票据111,108,916.8120,272,747153,776,528114,462,580
应付账款641,484,497.9358,040,295.98291,917,318.38319,669,845.24
预收款项195,961.6---
合同负债25,798,633.5619,981,801.1329,846,876.1731,226,783.93
应付职工薪酬28,276,901.5629,638,323.1228,868,295.4872,158,192.13
应交税费16,840,887.1921,239,399.923,355,923.03173,371,022.47
其他应付款合计1,517,305,298.641,549,263,336.351,401,880,488.921,354,303,519.53
一年内到期的非流动负债16,331,584.06114,241,288.81105,594,863.7103,612,420.73
其他流动负债775,817.4599,454.03895,406.27936,803.51
流动负债平衡项目0000
流动负债合计2,524,566,186.212,379,661,833.822,203,444,033.282,339,812,000.87
非流动负债:
长期借款556,348,953.58447,625,743.96442,820,248.84404,711,635.34
应付债券1,678,593,175.11,657,211,094.81,633,959,986.971,610,968,442.8
预计负债23,506,813.8344,017,334.1623,853,727.7736,334,172.95
递延收益337,629,973.94340,554,562.37384,665,204.28383,103,199.16
递延所得税负债24,366,388.8624,407,944.2426,046,134.3626,084,051.15
非流动负债平衡项目0000
非流动负债合计2,620,445,305.312,513,816,679.532,511,345,302.222,461,201,501.4
负债平衡项目0000
负债合计5,145,011,491.524,893,478,513.354,714,789,335.54,801,013,502.27
所有者权益(或股东权益):
实收资本(或股本)1,116,912,4631,116,912,4321,116,912,3451,120,493,735
其他权益工具511,137,271.61511,137,552.82511,138,319.76511,140,160.43
资本公积5,369,234,605.445,369,195,577.95,372,351,370.75,489,713,970.03
减:库存股---19,997,159.64
盈余公积242,899,806.53242,899,806.53242,899,806.53242,899,806.53
未分配利润2,338,138,521.012,151,519,173.881,846,550,476.781,641,087,656.53
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计9,578,322,667.599,391,664,543.139,089,852,318.778,985,338,168.88
股东权益平衡项目0000
股东权益合计9,578,322,667.599,391,664,543.139,089,852,318.778,985,338,168.88
负债和股东权益合计14,723,334,159.1114,285,143,056.4813,804,641,654.2713,786,351,671.15
公告日期2023-10-272023-08-262023-04-242023-04-24
审计意见(境内)标准无保留意见
TOP↑